Medcrave Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 358.66%
- Profit Growth 561.46%
- Ebitda 561.46%
- Net Worth 162.47%
- Total Assets 91.56%
About Medcrave Biomedicals
Medcrave Biomedicals Private Limited (MBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 17 August 2021 (Three years and six months 8 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rita Jadhav and Ramchandra Jadhav serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33300MH2021PTC365970
- Company No.
365970
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medcrave Biomedicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramchandra Jadhav  | Director | 17-Aug-2021 | Current |
| Rita Jadhav | Director | 17-Aug-2021 | Current |
Financial Performance of Medcrave Biomedicals.
Medcrave Biomedicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 358.66% increase. The company also saw a substantial improvement in profitability, with a 561.46% increase in profit. The company's net worth Soared by an impressive increase of 162.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medcrave Biomedicals?
In 2023, Medcrave Biomedicals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medimark Diagnostics Private LimitedRamchandra Jadhav is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medcrave Biomedicals?
Medcrave Biomedicals has a workforce of 0 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medcrave Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medcrave Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.